SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia.
Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, White RF, McVey MJ, Legos JJ, Erhardt JA, Nelson AH, Ohlstein EH, Hunter AJ, Ward K, Smith BR, Adams JL, Parsons AA.
Barone FC, et al. Among authors: mcvey mj.
J Pharmacol Exp Ther. 2001 Feb;296(2):312-21.
J Pharmacol Exp Ther. 2001.
PMID: 11160612